Re-evaluation of the dysfunction of mitochondrial respiratory chain in skeletal muscle of patients with Parkinson's disease

Journal of Neural Transmission

Volumn 112, Issue 4, 2005, Pages 499-518

  Winkler Stuck, K ^a   Kirches, E ^a   Mawrin, C ^a   Dietzmann, K ^a   Lins, H ^a   Wallesch, C W ^a   Kunz, W S ^b   Wiedemann, F R ^a,c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Mitochondria; Mitochondrial DNA; Oxidative phosphorylation; Parkinson's disease; Skeletal muscle

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; BRAIN MITOCHONDRION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; METABOLIC REGULATION; MUSCLE CELL; OXYGEN CONSUMPTION; PARKINSON DISEASE; PATIENT; PERMEABILITY; POINT MUTATION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SKELETAL MUSCLE;

ADULT; AGED; CELL RESPIRATION; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT; FEMALE; FREE RADICALS; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUSCLE, SKELETAL; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PARKINSON DISEASE; POINT MUTATION;

EID: 17644416028     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0195-y     Document Type: Article

References (58)

1. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 290: 457-465
2. Anderson JJ, Bravi D, Ferrari R, Davis TL, Baronti F, Chase TN, Dagani F (1993) No evidence for altered muscle mitochondrial function in Parkinson's disease. J Neurol Neurosurg Psychiatry 56: 477-480
3. Bergmeier HU (1974) Citratsyntase. In: Bergmeier HU (ed) Methoden der enzymatischen Analyse. Wissenschaftsverlag, Weinheim, pp 727-733
4. Bindoff LA, Birch-Machin M, Cartlidge NE, Parker WD Jr, Turnbull DM (1989) Mitochondrial function in Parkinson's disease. Lancet 2: 49
5. Bindoff LA, Birch-Machin MA, Cartlidge NE, Parker WD Jr, Turnbull DM (1991) Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease. J Neurol Sci 104: 203-208
6. Blin O, Desnuelle C, Rascol O, Borg M, Peyro Saint PH, Azulay JP, Bille F, Figarella D, Coulom F, Pellissier JF (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J Neurol Sci 125: 95-101
7. Bohr VA, Stevnsner T, Souza-Pinto NC (2002) Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 286: 127-134
8. Byrne E (2002) Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? J Clin Neurosci 9: 497-501
9. Cardellach F, Marti MJ, Fernandez-Sola J, Marin C, Hoek JB, Tolosa E, Urbano-Marquez A (1993) Mitochondrial respiratory chain activity in skeletal muscle from patients with Parkinson's disease. Neurology 43: 2258-2262
10. Chen D, Cao G, Hastings T, Feng Y, Pei W, O'Horo C, Chen J (2002) Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J Neurochem 81: 1273-1284
11. DiDonato S, Zeviani M, Giovannini P, Savarese N, Rimoldi M, Mariotti C, Girotti F, Caraceni T (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology 43: 2262-2268
12. Di Monte DA, Sandy MS, Jewell SA, Langston JW (1993) Oxidative phosphorylation by intact muscle mitochondria in Parkinson's disease. Neurodegeneration 2: 275-281
13. Dubowitz V, Brooke MH (1973) Muscle biopsy: a modern approach. Saunders, Philadelphia
14. Gasser T (2001) Genetics of Parkinson's disease. J Neurol 248: 833-840
15. Grishko VI, Druzhyna N, LeDoux SP, Wilson GL (1999) Nitric oxide-induced damage to mtDNA and its subsequent repair. Nucl Acids Res 27: 4510-4516
16. Hattori N, Tanaka M, Ozawa T, Mizuno Y (1991) Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease. Ann Neurol 30: 563-571
17. Heinrich R, Rapoport TA (1974) A linear steady-state treatment of enzymatic chains. Critique of the crossover theorem and a general procedure to identify interaction sites with an effector. Eur J Biochem 42: 97-105
18. Helbock HJ, Beckman KB, Shigenaga MK, Walter PB, Woodall AA, Yeo HC, Ames BN (1998) DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci USA 95: 288-293
19. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA (1990) A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 46: 428-433
20. Jenner P (2003) Oxidative stress in Parkinson's disease. Ann Neurol 53 [Suppl 3]: S26-S36
21. Kacser H, Burns JA (1973) Rate control of biological processes. Cambridge University Press, London
22. Karahalil B, Hogue BA, Souza-Pinto NC, Bohr VA (2002) Base excision repair capacity in mitochondria and nuclei: tissue-specific variations. FASEB J 16: 1895-1902
23. Kirches EJ, Winkler K, Warich-Kirches M, Szibor R, Wien F, Kunz WS, von Bossanyi P, Bajaj PK, Dietzmann K (1998) mtDNA depletion and impairment of mitochondrial function in a case of a multisystem disorder including severe myopathy. J Inherit Metab Dis 21: 400-408
24. Koutsilieri E, Scheller C, Grunblatt E, Nara K, Li J, Riederer P (2002) Free radicals in Parkinson's disease. J Neurol 249 [Suppl 2]: II1-II5
25. Kunz WS, Kuznetsov AV, Schulze W, Eichhorn K, Schild L, Striggow F, Bohnensack R, Neuhof S, Grasshoff H, Neumann HW (1993) Functional characterization of mitochondrial oxidative phosphorylation in saponin-skinned human muscle fibers. Biochim Biophys Acta 1144: 46-53
26. Kuznetsov AV, Winkler K, Kirches E, Lins H, Feistner H, Kunz WS (1997) Application of inhibitor titrations for the detection of oxidative phosphorylation defects in saponin-skinned muscle fibers of patients with mitochondrial diseases. Biochim Biophys Acta 1360: 142-150
27. Kuznetsov AV, Mayboroda O, Kunz D, Winkler K, Schubert W, Kunz WS (1998) Functional imaging of mitochondria in saponin-permeabilized mice muscle fibers. J Cell Biol 140: 1091-1099
28. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115(Pt 2): 333-342
29. Mason PA, Matheson EC, Hall AG, Lightowlers RN (2003) Mismatch repair activity in mammalian mitochondria. Nucl Acids Res 31: 1052-1058
30. Miro O, Cardellach F, Barrientos A, Casademont J, Rotig A, Rustin P (1998) Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers. J Neurosci Methods 80: 107-111
31. MITOMAP (2004) A human mitochondrial genome database, http://www.mitomap.org
32. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450-1455
33. Nakagawa-Hattori Y, Yoshino H, Kondo T, Mizuno Y, Horai S (1992) Is Parkinson's disease a mitochondrial disorder? J Neurol Sci 107: 29-33
34. Orth M, Schapira AH (2001) Mitochondria and degenerative disorders. Am J Med Genet 106: 27-36
35. Orth M, Schapira AH (2002) Mitochondrial involvement in Parkinson's disease. Neurochem Int 40: 533-541
36. Pallotti F, Chen X, Bonilla E, Schon EA (1996) Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am J Hum Genet 59: 591-602
37. Reichmann H, Janetzky B, Bischof F, Seibel P, Schols L, Kuhn W, Przuntek H (1994) Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. Eur Neurol 34: 263-267
38. Reid FM, Vernham GA, Jacobs HT (1994) A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 3: 243-247
39. Richter G, Sonnenschein A, Grunewald T, Reichmann H, Janetzky B (2002) Novel mitochondrial DNA mutations in Parkinson's disease. J Neural Transm 109: 721-729
40. Saks VA, Veksler VI, Kuznetsov AV, Kay L, Sikk P, Tiivel T, Tranqui L, Olivares J, Winkler K, Wiedemann F, Kunz WS (1998) Permeabilized cell and skinned fiber techniques in studies of mitochondrial function in vivo. Mol Cell Biochem 184: 81-100
41. Saxowsky TT, Matsumoto Y, Englund PT (2002) The mitochondrial DNA polymerase beta from Crithidia fasciculata has 5′-deoxyribose phosphate (dRP) lyase activity but is deficient in the release of dRP. J Biol Chem 277: 37201-37206
42. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269
43. Sciacco M, Bonilla E (1996) Cytochemistry and immunocytochemistry of mitochondria in tissue sections. Meth Enzymol 264: 509-521
44. Shoffner JM, Watts RL, Juncos JL, Torroni A, Wallace DC (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30: 332-339
45. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184
46. Singer TP, Ramsay RR, Ackrell BA (1995) Deficiencies of NADH and succinate dehydrogenases in degenerative diseases and myopathies. Biochim Biophys Acta 1271: 211-219
47. Sperl W, Skladal D, Gnaiger E, Wyss M, Mayr U, Hager J, Gellerich FN (1997) High resolution respirometry of permeabilized skeletal muscle fibers in the diagnosis of neuromuscular disorders. Mol Cell Biochem 174: 71-78
48. Taylor DJ, Krige D, Barnes PR, Kemp GJ, Carroll MT, Mann VM, Cooper JM, Marsden CD, Schapira AH (1994) A 31P magnetic resonance spectroscopy study of mitochondrial function in skeletal muscle of patients with Parkinson's disease. J Neurol Sci 125: 77-81
49. Trounce IA, Kim YL, Jun AS, Wallace DC (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Meth Enzymol 264: 484-509
50. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811
51. Van Kuilenburg AB, Dekker HL, Van den BC, Nieboer P, Van Gelder BF, Muijsers AO (1991) Isoforms of human cytochrome-c oxidase. Subunit composition and steady-state kinetic properties. Eur J Biochem 199: 615-622
52. Vielhaber S, Kudin A, Winkler K, Wiedemann F, Schroder R, Feistner H, Heinze HJ, Elger CE, Kunz WS (2003) Is there mitochondrial dysfunction in amyotrophic lateral sclerosis skeletal muscle? Ann Neurol 53: 686-687
53. Wharton DC, Tzagoloff A (1967) Cytochrome oxidase from beef heart mitochondria. Meth Enzymol 10: 245-250
54. Wiedemann FR, Winkler K, Kuznetsov AV, Bartels C, Vielhaber S, Feistner H, Kunz WS (1998) Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 156: 65-72
55. Wiedemann FR, Winkler K, Lins H, Wallesch CW, Kunz WS (1999) Detection of respiratory chain defects in cultivated skin fibroblasts and skeletal muscle of patients with Parkinson's disease. Ann NY Acad Sci 893: 426-429
56. Wiedemann FR, Vielhaber S, Schroder R, Elger CE, Kunz WS (2000) Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal Biochem 279: 55-60
57. Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA (2002) Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J Neurochem 80: 616-625
58. Zhang C, Linnane AW, Nagley P (1993) Occurrence of a particular base substitution (3243 A to G) in mitochondrial DNA of tissues of ageing humans. Biochem Biophys Res Commun 195: 1104-1110